Bartonella henselae bacteremia in a mother and son potentially associated with tick exposure by Ricardo G Maggi et al.
Maggi et al. Parasites & Vectors 2013, 6:101
http://www.parasitesandvectors.com/content/6/1/101RESEARCH Open AccessBartonella henselae bacteremia in a mother and
son potentially associated with tick exposure
Ricardo G Maggi1,3*, Marna Ericson2, Patricia E Mascarelli1, Julie M Bradley1 and Edward B Breitschwerdt1Abstract
Background: Bartonella henselae is a zoonotic, alpha Proteobacterium, historically associated with cat scratch
disease (CSD), but more recently associated with persistent bacteremia, fever of unknown origin, arthritic and
neurological disorders, and bacillary angiomatosis, and peliosis hepatis in immunocompromised patients. A family
from the Netherlands contacted our laboratory requesting to be included in a research study (NCSU-IRB#1960),
designed to characterize Bartonella spp. bacteremia in people with extensive arthropod or animal exposure. All four
family members had been exposed to tick bites in Zeeland, southwestern Netherlands. The mother and son were
exhibiting symptoms including fatigue, headaches, memory loss, disorientation, peripheral neuropathic pain, striae
(son only), and loss of coordination, whereas the father and daughter were healthy.
Methods: Each family member was tested for serological evidence of Bartonella exposure using B. vinsonii subsp.
berkhoffii genotypes I-III, B. henselae and B. koehlerae indirect fluorescent antibody assays and for bacteremia using
the BAPGM enrichment blood culture platform.
Results: The mother was seroreactive to multiple Bartonella spp. antigens and bacteremia was confirmed by PCR
amplification of B. henselae DNA from blood, and from a BAPGM blood agar plate subculture isolate. The son was
not seroreactive to any Bartonella sp. antigen, but B. henselae DNA was amplified from several blood and serum
samples, from BAPGM enrichment blood culture, and from a cutaneous striae biopsy. The father and daughter were
seronegative to all Bartonella spp. antigens, and negative for Bartonella DNA amplification.
Conclusions: Historically, persistent B. henselae bacteremia was not thought to occur in immunocompetent
humans. To our knowledge, this study provides preliminary evidence supporting the possibility of persistent
B. henselae bacteremia in immunocompetent persons from Europe. Cat or flea contact was considered an unlikely
source of transmission and the mother, a physician, reported that clinical symptoms developed following tick
exposure. To our knowledge, this is the first time that a B. henselae organism has been visualized in and amplified
from a striae lesion. As the tick bites occurred three years prior to documentation of B. henselae bacteremia, the
mode of transmission could not be determined.
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Due to complex nutritional requirements and slow div-
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Bartonella are highly fastidious microorganisms that are
difficult to document microbiologically in patient blood* Correspondence: rgmaggi@ncsu.edu
1Intracellular Pathogens Research Laboratory, Center for Comparative
Medicine and Translational Research, College of Veterinary Medicine, North
Carolina State University, Raleigh, NC, USA
3Galaxy Diagnostics Inc., Research Triangle Park, Durham, USA
Full list of author information is available at the end of the article
© 2013 Maggi et al.; licensee BioMed Central
Commons Attribution License (http://creativec
reproduction in any medium, provided the oror tissue specimens [1]. Over the past decade, evolving
evidence supports the fact that these bacteria can induce
long-lasting intravascular infections in animals that serve
as reservoir-adapted hosts, whereas, more recently a
number of Bartonella sp. have been associated with per-
sistent bacteremia in immunocompetent human patients
experiencing a spectrum of symptoms and somewhat di-
verse disease pathologies [2,3]. On a comparative med-
ical basis, Bartonella infection induces similar pathology
in dogs, people, and other animals [3,4]. Infection with
one or more Bartonella sp. has also been associated withLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Maggi et al. Parasites & Vectors 2013, 6:101 Page 2 of 9
http://www.parasitesandvectors.com/content/6/1/101fever of unknown origin [5-9], and arthritic and neuro-
logical disorders [10-12].
In an effort to overcome limitations associated with the
molecular detection and isolation of Bartonella spp. from
animals and immunocompetent human patients, our la-
boratory developed a novel diagnostic platform based on
biochemical optimization of a modified insect-cell culture
liquid medium (Bartonella alpha Proteobacteria Growth
Medium or BAPGM) [13]. The BAPGM platform consists
of PCR amplification of Bartonella DNA from the patient’s
extracted blood and serum samples before, and after
BAPGM enrichment culture and from isolates, if obtained,
following subculture of pre-enriched samples onto
blood agar plates. Research utilization of this testing plat-
form has facilitated the documentation of B. henselae
bacteremia in patients from the Australia [14], England
[14], and the United States [10-12,15]. In addition,
utilization of the BAPGM enrichment blood culture plat-
form has facilitated the isolation or molecular detection of
other Bartonella spp. including Bartonella vinsonii subsp.
berkhoffii genotypes I and II [10-12,15,16], Bartonella
koehlerae [10,12,14,17], Candidatus Bartonella melophagi
[18], and a novel Bartonella sp. related to Bartonella vo-
lans [19], from the blood of immunocompetent humans
[10,11,13]. Standardized precautions are routinely used in
our laboratory to avoid DNA contamination and negative
controls are used in each step of the testing platform, in-
cluding culture, DNA extraction and PCR negative con-
trols. All conventional PCR amplicons are sequenced to
confirm the Bartonella species and 16S-23S ITS strain
type. In this study, four members of a family from the
Netherlands were tested for serological, microbiological
(isolation) or molecular (PCR amplification and DNA se-
quencing) evidence of Bartonella exposure or bacteremia,
using five indirect fluorescent antibody assays and the
Bartonella alpha Proteobacteria growth medium (BAPGM)
enrichment culture platform, respectively. In addition, skin
biopsies were obtained surgically from the son for BAPGM




While reviewing recently published literature relative to
potential transmission of Bartonella species by ticks
[20-24], the mother, a 58-year-old anesthesiologist from
the Netherlands contacted one of the investigators in our
laboratory (EBB) by email and requested BAPGM enrich-
ment blood culture testing to determine if she and her son
could have been infected with a Bartonella sp. following
tick bites. It was ultimately decided that the family would
be tested in conjunction with an ongoing research study
designed to determine the prevalence of bacteremia in
people with animal and arthropod exposure. This researchstudy was reviewed and approved by the North Carolina
State University Institutional Review Board (NCSU
IRB#1960) to assure conformity with all confidentiality
and patient assurance laws in the United States. In July
2008, prior to the onset of illness in the mother and son,
all four family members had experienced tick bites at the
family vacation home in Zeeland, located in southwestern
Netherlands, where they reported a large deer population.
Tick attachments had also occurred during subsequent
summer vacations. The family did not own a cat or dog,
and all family members denied exposure to cats and cat
fleas. During the three years prior to testing in the Intracel-
lular Pathogens Research Laboratory (IPRL), the mother
reported fatigue, headaches, memory loss, irritability,
disorientation, chest pain, syncope (two episodes), fine
tremors, shoulder pain, joint pain, loss of coordination, and
peripheral neuropathic pain involving the arms. The son
(an 18-year-old student) reported an illness of three-year
duration, with symptoms including: fatigue, headaches, fine
tremors, red conjunctivae, cervical lymphadenopathy, and
striae involving both legs and the buttock. In the context of
this manuscript, striae are irregular bands, stripes or lines
in the skin. Between July 2009 and July 2011, both the
mother and son underwent multiple diagnostic evaluations
for infectious and non-infectious diseases. Both had been
treated for a potential Borrelia sp. infection with multiple
antibiotic combinations (azithromycin, cefuroxime, metro-
nidazole, rifampin, tetracycyline) for at least 6 weeks dur-
ation, on several occasions. The historical response to
antibiotics was inconsistent and difficult to assess, but in
general, symptoms would diminish while receiving antibi-
otics and reoccur weeks to months after antibiotic admin-
istration ended. The last date in which the mother and son
took antibiotics was May 24, 2011 and July 7, 2011, re-
spectively. The father (64-year-old investment banker) and
daughter (20-year-old medical student) were not symptom-
atic prior to or at the time of sample collection. As a phys-
ician, the mother decided that shipping samples from
Europe to the United States might compromise sample in-
tegrity, thereby contributing to false negative test results.
Therefore, after flying to North Carolina, the mother and
son’s blood samples were aseptically collected during the
last week of July 2011, whereas the father and daughter’s
samples were collected the first week of August 2011. After
the two week sample collection period, the family flew
back to the Netherlands to await research testing results,
which required months to complete. Three aseptically col-
lected blood and serum samples were obtained during a
one-week period from the mother, father, son and daugh-
ter. Three skin biopsy samples, which included a blue
nevus located over the right deltoid, and a striae lesion
(0.4 × 0.3 cm, excised to a depth of 0.5 cm) located on the
left thigh, were surgically obtained from the son at a hos-
pital in Raleigh, North Carolina, during the same time
Table 1 Indirect fluorescent serum antibody results for
the four family members
Patient Collection date Bvb TI Bvb TII Bvb TIII Bh Bk
Son
7/25/2011 <16 <16 <16 <16 <16
7/27/2011 <16 <16 <16 <16 <16
7/29/2011 <16 <16 <16 <16 <16
Mother
7/25/2011 <16 64 <16 64 64
7/27/2011 <16 64 64 64 64
7/29/2011 <16 64 <16 64 64
Daughter
8/1/2011 <16 <16 <16 32 <16
8/2/2011 <16 <16 <16 32 <16
8/5/2011 <16 <16 <16 32 <16
Father
8/1/2011 <16 <16 <16 32 <16
8/2/2011 <16 <16 <16 32 <16
8/5/2011 <16 <16 <16 32 <16
Bh: B. henselae; Bk: B. koehlerae; Bvb: B. vinsonii subsp. berkhoffii.
TI,TII, TIII denote B. vinsonii subsp. berkhoffii genotypes I, II and III, respectively.
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and skin biopsy samples were processed and tested in the
IPRL, as described below. Histopathological examination
of hematoxylin and eosin stained tissue sections was
performed by the consulting human pathologist for the
local hospital. Frozen tissues were sent to the Cutaneous
Imaging Center, Department of Dermatology and Center
for Drug Design, University of Minnesota to determine if
Bartonella organisms could be visualized.
Bartonella spp. IFA testing
Antibody seroreactivity to B. vinsonii subsp. berkhoffii
genotypes I, II and III, B. henselae (strain Houston I), and
B. koehlerae were determined using previously described
indirect fluorescent antibody tests [10,11,25].
BAPGM enrichment culture
The BAPGM enrichment culture platform, which has been
employed by several research laboratories [26-28] was used
to assess for Bartonella sp. bacteremia. Briefly the proced-
ure included inoculation of 2 ml of blood and up to 2 ml
of serum collected the same day into a culture flask
containing 10 ml of BAPGM. Cultures were incubated for
up to 14 days at 36°C with 5% CO2 and 100% humidity
with constant agitation. A milliliter of each enrichment cul-
ture sample was sub-inoculated onto blood agar plates
(10% rabbit blood, TSA II) at 7 and 14 days after incuba-
tion of the BAPGM flask for potential colony formation.
For each patient sample tested using the BAPGM platform,
an un-inoculated BAPGM culture was processed in an
identical and simultaneous manner to monitor for poten-
tial laboratory contamination (quality assurance).
DNA extraction, PCR amplification and DNA sequencing
Using established assays, PCR targeting the Bartonella
16S-23S intergenic spacer (ITS) region was used to amp-
lify Bartonella spp. DNA from extracted blood, serum,
skin biopsies, BAPGM enrichment cultures and isolates
[10]. All PCR products obtained after amplification of
extracted DNA from blood, serum and tissue samples,
after BAPGM enrichment, and from agar plate colonies
were sequenced directly or after cloning. Bacterial species
and strain were defined by comparing DNA sequence
similarities with other sequenced bacteria deposited in the
GenBank database using the Basic Local Alignment
Search Tool (Blast version 2.0).
Bartonella confocal microscopy
An excised skin biopsy sample from the son (striae lesion)
was drop-fixed in formalin and stored at room temperature.
As a negative control, a scalp skin 4-mm punch biopsy was
drop-fixed in Zamboni’s fixative (0.03% (w/v) picric acid
and 2% (w/v) paraformaldehyde) for 48 h at 4°C and then
transferred to a 20% sucrose solution with 0.05% sodiumazide in PBS for storage. Processing and multi-staining of
tissues specimens was performed according to a previously
published procedure [29,30]. Vertical sections, 60-microns
thick, were mounted in and cut on a cryostat. Floating
sections were then incubated with primary antibodies to
Collagen Type IV at a 1:200 dilution (Southern Biotech,
1340–01), donkey anti-goat Cy3 at 1:500 dilution (Jackson
Immunoresearch, West Grove, PA), and a mouse antibody
to Bartonella henselae at a 1:100 dilution (Abcam, ab704-
250) plus donkey anti-mouse Cy5 at a 1:500 dilution
(Jackson Immunoresearch). Washed samples were subse-
quently fixed to cover slips in agar, dehydrated in ethanol,
cleared with methyl salicylate, and mounted in DEPEX
(Electron Microscopy Sciences, Hatfield, PA).
Results
The son was not seroreactive to B. henselae, B. koehlerae
or B. vinsonii subsp. berkhoffii genotype I, II or III antigens
by IFA testing (Table 1). However, B. henselae (16S-23S
SA2 strain type) DNA was amplified and successfully se-
quenced from his blood, serum, a BAPGM enrichment
blood culture, and from the striae biopsy sample (Table 2).
Bartonella spp. DNA was not amplified from the biopsy of
the son’s blue nevus. In contrast to her son, the mother
was seroreactive to B. henselae (at an endpoint titer of
1:64), B. koehlerae (1:64), and B. vinsonii subsp. berkhoffii
genotypes II and III antigens (both 1:64), but was
not seroreactive to B. vinsonii subsp. berkhoffii genotype
I. Bartonella henselae SA2 bacteremia was confirmed in
the mother by PCR amplification and DNA sequencing
(460/460 bp homology with GenBank AF369529) of 16S-
23S ITS PCR amplicons from an extracted blood sample
and from colonies obtained on blood agar plates following
BAPGM enrichment [10,11,18] from the same collection
date. Isolation of B. henselae from the mother’s blood and
Table 2 Bartonella spp. blood, serum, BAPGM enrichment blood culture, subculture and tissue PCR testing results for
the four family members
Patient Sample type Collection date PCR sample PCR culture PCR isolate
Son
Serum 7/29/2011 Neg Neg Neg
Blood 7/29/2011 Neg
Blue nevus 7/25/2011 Neg Neg Neg
Normal skin 7/25/2011 Neg Neg Neg
Striae 7/25/2011 BhSA2 Neg Neg
Serum 7/25/2011 BhSA2 Neg Neg
Blood 7/25/2011 BhSA2
Serum 7/27/2011 BhSA2 Bh SA2 Neg
Blood 7/27/2011 BhSA2
Mother
Serum 7/25/2011 Neg Neg Neg
Blood 7/25/2011 Neg
Serum 7/27/2011 Neg Neg Bh SA2
Blood 7/27/2011 BhSA2
Serum 7/29/2011 Neg Neg Neg
Blood 7/29/2011 Neg
Daughter
Serum 8/1/2011 Neg Neg Neg
Blood 8/1/2011 Neg
Serum 8/2/2011 Neg Neg Neg
Blood 8/2/2011 Neg
Serum 8/5/2011 Neg Neg Neg
Blood 8/5/2011 Neg
Father
Serum 8/1/2011 Neg Neg Neg
Blood 8/1/2011 Neg
Serum 8/2/2011 Neg Neg Neg
Blood 8/2/2011 Neg
Serum 8/5/2011 Neg Neg Neg
Blood 8/5/2011 Neg
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culture from the son supported active infection with viable
intravascular bacteria. The father and daughter were not
seroreactive to the Bartonella spp. test antigens used in this
study and B. henselae DNA was not amplified from any of
their blood, serum or BAPGM enrichment blood cultures.
As detailed in previous studies [10,11], Bartonella DNA
was not amplified from any of the simultaneously processed
BAPGM negative culture controls (results not shown).
The gross appearance of the son’s striae are depicted
in Figure 1A and 1B. Histopathology of the right deltoid
skin lesion contained features of a blue nevus. The striae
lesional biopsy from the left thigh contained minimal
nonspecific superficial perivascular chronic inflamma-
tion (Figure 1C and 1D). Immunostaining of the striae
tissue from the son’s skin biopsy revealed B. henselae
immuno-positive staining within the dermis and by con-
focal microscopy imaging, the bacteria were external to
vascular tissue (Figure 2).After these results were obtained, the son elected to not
be treated with additional antibiotics. During 2012 he
remained mostly healthy, and passed Propedeuse exam
Cum Laude. The striae regressed spontaneously leaving
slight, colorless and painless marks. Conjunctivitis and the
fine motor tremor have persisted. Psoriasis was diagnosed
in 2012 for which he is being treated with vitamin supple-
mentation and immune stimulants. The mother also did
not seek treatment for B. henselae bacteremia until several
months after test results became available, when she devel-
oped severe myalgia, tendinitis involving several joints and
paresthesias. She was treated with intraveneous ceftriaxone
4 gram twice a week for six months. After three months of
antibiotic therapy, Bartonella serology was reported as
positive (IFA titer 1:32—normal < 32). During the final two
months of antibiotic therapy, rifampin, hyperthermic ther-
apy every day (sauna) and hyperbaric oxygen therapy by
mask in a high-pressure cabin 2.4 bar, for 75 minutes each
day were administered for 45 days. None of these therapies
Figure 1 Gross appearance of striae located on the thigh of the son (A & B, photographs provided by the family) and the
hematoxylin/eosin stained striae tissue biopsy (C & D) illustrating (arrows) minimal nonspecific superficial perivascular
chronic inflammation.
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father and daughter have remained healthy.Discussion
In this study, B. henselae bacteremia was confirmed in the
two symptomatic family members, but not in the two his-
torically healthy family members. Although the symptoms
that developed in 2008 as reported by the physician
and her son were similar to questionnaire respondent
symptoms reported by other patients with B. henselae
bacteremia [10,11], it is not possible to determine whether
the symptoms in these two family members were due
in part or total to infection with this organism. Unless
re-infection was occurring, prior efforts to eliminate
B. henselae with antibiotics were not successful, further
supporting the possibility that antibiotic treatment failure
can occur in a subset of B. henselae bacteremic patients
[14,31]. As our research group was not involved in patient
management decisions prior to or after B. henselae
bacteremia was confirmed, the purpose of this report wasFigure 2 Photomicrographs captured using laser scanning confocal m
in the striae skin biopsy obtained from the son’s thigh (right panel, s
subject also immunostained with B. henselae antibody. No bacteria were vi
red blood cells are partially visible (pseudo-colored green). Both samples al
(pseudo-colored red). Note bacteria within skin appear external to vascular
total thickness 15 microns. Scale bar = 10 microns.to provide evidence supporting B. henselae bacteremia in
two immmunocompetent individuals from Europe, who
believed that tick transmission was the most likely source
of their infections. During the previous three years, all four
family members reported tick bites while vacationing in
southwestern Holland and all denied exposure to cats. As
B. henselae DNA was successfully amplified and sequenced
from one of the son’s BAPGM enrichment blood cultures
and from a subculture isolate obtained from the mother’s
blood, bacteremia (viable bacteria) was confirmed in both
individuals despite prior administration of antibiotics. Only
one of three blood culture sample sets from the mother
and the son resulted in enrichment culture or isolation evi-
dence to support the presence of bacteremia, which is con-
sistent with prior experience with the BAPGM platform
when testing sequentially-obtained blood samples from
sick human patients [10,11,16,17,19,32]. Presumably, fail-
ure to document infection in two of the three sample sets
is potentially due to a relapsing pattern of bacteremia in
humans [33-36], as has been reported in experimentally-
infected cats [37,38] and rodents [33,39,40]. Due toicroscopy demonstrating immunoreactive B. henselae organisms
mall green particles). Left panel is scalp skin from a non-infected
sualized in control sections, although relatively large auto fluorescent
so stained with collagen IV to highlight immunoreactive vascular tissue
tissues. Images are projections of 31, 0.48-micron thick optical sections,
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plating methods, and PCR following DNA extraction dir-
ectly from patient samples, our research group developed
and have used a combined method that incorporates PCR
from extracted blood, serum and BAPGM enrichment
blood culture [10,11,17]. This study further supports the
enhanced diagnostic sensitivity of the BAPGM enrichment
blood culture platform for documentation of Bartonella
spp. bacteremia in immunocompetent patients, and pro-
vides additional support for the need to test three sample
sets obtained during a one week collection period [32].
In addition to documentation of bacteremia, immuno-
histochemical confocal microscopy was used to visualize
B. henselae organisms in the son’s striae tissue biopsy.
This observation provides preliminary evidence to
support a potential association between B. henselae
infection and striae. Although lay publications have fre-
quently reported [41,42] that striae are caused by
Bartonella sp. infections, to our knowledge there are no
scientific publications that have investigated, reported,
or confirmed this possibility. Clearly, additional immu-
nohistochemical studies of striae would be of interest to
determine if persistent Bartonella sp. bacteremia could
contribute to the development of these skin lesions in
human patients.
As is true throughout much of the world, B. henselae in-
fection in immunocompetent people has been reported
previously in the Netherlands in association with the diag-
nosis of typical or atypical cases of cat scratch disease
(CSD) [43,44]. Cats, infected with B. henselae by cat fleas
(Ctenocephalides felis), develop a bacteremia that can per-
sist for years [37,45-49]. The term cat scratch disease is
clearly of historical medical importance, but continued use
of the term as a sole reference to B. henselae or other
Bartonella sp. infections is potentially detrimental for pa-
tient diagnosis and patient management decisions. Briefly,
B. henselae, the acknowledged cause of CSD, has also been
documented (by PCR or isolation) in dogs [13,25,50-54],
dolphins [55,56], feral swine [57], horses [58-60], and
Beluga whales [61]. In North America, B. henselae is the
most frequent Bartonella species isolated from bacteremic
sick dogs [54] and people [10,11,62]. In a recent report of a
patient with neuroretinitis in Australia, a well-documented
ocular pathology induced by B. henselae, bartonellosis was
diagnosed following the bite (sting) of a bull ant (genus
Myrmecia) [21]. Those authors also advocated for medical
use of the more inclusive term bartonellosis. Thus, because
of alternative vectors, numerous accidental or reservoir
hosts, and the seemingly broad spectrum of disease mani-
festations, referring to all B. henselae infections as CSD is
a contradiction in fact, and the use of the more globally
applicable term such as bartonellosis is suggested. In
addition, CSD is considered a self-limiting infection for
which antibiotic therapy is not recommended, whereasmore recent evidence indicates that antibiotic elimination
of B. henselae bacteremia can be extremely challenging,
and potentially difficult to achieve [19,31]. Interestingly,
molecular differences among B. henselae isolates based on
16S rDNA sequences and multiple-locus variable number
tandem repeat analysis (MLVA), have documented the
presence of two different B. henselae genotypes, one more
frequently observed in association with human infections
(genotype I), and the second (genotype II) most often iso-
lated from bacteremic cats, suggesting that genotype II
isolates may be minimally or nonpathogenic for humans
(CSD) as compared with a more pathogenic and zoonotic
genotype I [63,64].
In recent years, a substantial number of European stud-
ies have reported the presence of B. henselae DNA in
ticks, including I. ricinus [24,65-76], suggesting that ticks
may act as an important ecological reservoir for this
Bartonella species. In addition, several recent publications
have provided indirect [22,23] or experimental vector
competence evidence [24] to support transmission of
Bartonella spp. (including B. henselae, B. birtlesii, and
B. vinsonii subsp. berkhoffii) by ticks (including I. ricinus)
[22-24]. Two previous studies have not documented
Bartonella spp. DNA in ticks from the Netherlands
[46,77], where this family experienced tick exposures. Al-
though not reported specifically in the results, B. henselae
SA2 strain DNA was amplified and sequenced from two I.
ricinus ticks from Klasdorf, Brandenburg, Germany, by
targeting the 16S-23S rRNA intergenic spacer region [73]
(Kempf VA, Maggi RG, unpublished data). The DNA se-
quences derived from these two ticks were identical to
the B. henselae DNA sequences obtained from the two
bacteremic people in this report. Interestingly, the
remaining eight ticks that were sequenced as part of that
study to confirm the Bartonella species and strain type
contained a B. henselae 16S-23S Houston 1 DNA and
were collected in southern Germany, France and Portugal,
suggesting the possibility of B. henselae strain variation
among ticks. It is also important to consider the tick life
stage, as in that study the odds of detecting B. henselae
DNA was 14 fold higher in nymphal ticks as compared to
adult ticks [73]. In addition, differences in PCR sensitivity
among studies and differences in Bartonella sp. gene tar-
gets used to test tick DNA extractions can contribute to
divergent findings among laboratories, when testing ticks
from the same location. Most previous studies designed to
detect and identify Bartonella species in I. ricinus ticks
from Europe have targeted the citrate synthase (gltA) and
16S rRNA genes. Unfortunately, these genes have very
limited genetic variability and therefore are not optimal
to differentiate among B. henselae strains. Clearly the
role of ticks as potential vectors for transmission of
Bartonella sp. to animals and humans deserves additional
research consideration.
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Although B. henselae infection was documented by PCR
amplification and DNA sequencing in both of the sick
members of this family, there may or may not be a causal
relationship between the bacteria and the reported symp-
toms. Bartonella serology was supportive of B. henselae in-
fection in the mother, but not in the son, further supporting
reports of seronegative Bartonella sp. bacteremia in human
patients [10,11,78,79]. Also, despite improvements in PCR
sensitivity, immunohistochemical methods are useful to fa-
cilitate the visualization of Bartonella species in patient tis-
sue specimens. Finally, as ticks removed from the patients
were not saved for PCR testing, it is not clear whether
infection with B. henselae was acquired by tick bites or by
another mode of transmission.
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